RGC
REGENCELL (RGC)
NASDAQ
$11.00+$0.49 (+4.66%)
Price as of Jun 23, 2026 7:22 PM EDT
  • N/A
    Market Cap
  • -55.65%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
06/30/2025
06/30/2024
06/30/2023
06/30/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
8,014
-93.61%
125,427
-52.25%
262,664
+939.22%
25,275
+1,503.74%
Research and Development Expense
-948,289
-11.06%
-1.1M
-32.59%
-1.6M
-37.04%
-2.5M
+473.13%
Depreciation and Amortization Expense
77,692
-74.59%
305,780
+4.31%
293,135
-35.47%
454,250
+1,617.00%
Total Operating Expenses
3.8M
-20.41%
4.7M
-24.50%
6.3M
-17.64%
7.6M
+451.47%
Operating Profit
-3.8M
-20.41%
-4.7M
-24.50%
-6.3M
-17.64%
-7.6M
+451.47%
Interest Income
185,772
-25.09%
248,000
+190.40%
85,400
+695.68%
10,733
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
185,772
-25.09%
248,000
+190.40%
85,400
+695.68%
10,733
N/A
Total Nonoperating Income and Expense
185,772
-50.26%
373,505
+76.73%
211,342
+810.37%
23,215
-32.94%
Income before Taxes
-3.6M
-17.85%
-4.4M
-28.03%
-6.1M
-20.18%
-7.6M
+463.92%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-3.6M
-16.68%
-4.3M
-26.73%
-5.9M
-22.69%
-7.6M
+463.92%
Net Income from Continuing Operations Applicable to Common
-3.6M
-17.85%
-4.4M
-26.76%
-6.0M
-180.01%
7.4M
+652.88%
Basic EPS and Net Income
-0.72
+118.18%
-0.33
-173.33%
0.45
-22.41%
0.58
N/A
Diluted EPS and Net Income
-0.72
+118.18%
-0.33
-173.33%
0.45
-22.41%
0.58
N/A
Basic Weighted Average Shares
494.5M
+3,700.00%
13.0M
0.00%
13.0M
+1.62%
12.8M
N/A
Diluted Weighted Average Shares
494.5M
+3,700.00%
13.0M
0.00%
13.0M
+1.62%
12.8M
+28.06%
Balance Sheet
Cash and Cash Equivalents
2.4M
-18.31%
3.0M
+89.24%
1.6M
-75.61%
6.4M
+10,700.66%
Short-Term Investments
2.5M
-50.44%
5.0M
-50.00%
10.0M
0.00%
10.0M
N/A
Cash and Cash Equivalents and Short-Term Investments
4.9M
-38.49%
8.0M
-31.16%
11.6M
-29.56%
16.4M
+27,532.00%
Total Current Assets
4.9M
-39.58%
8.1M
-30.18%
11.6M
-29.33%
16.4M
+24,499.61%
Accumulated Depreciation
857,267
+9.32%
784,165
+64.68%
476,164
+155.84%
186,119
+417.40%
Property and Plant and Equipment and Net
215,434
+52.00%
141,734
-67.85%
440,829
-38.14%
712,594
+770.45%
Total Long-Term Assets
852,769
+163.04%
324,198
-67.59%
1.0M
-36.45%
1.6M
+476.07%
Total Assets
5.8M
-31.79%
8.4M
-33.15%
12.6M
-29.95%
18.0M
+5,197.59%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
3.0M
N/A
N/A
N/A
Total Current Liabilities
663,673
+242.85%
193,578
-68.10%
606,914
+5.05%
577,764
-86.68%
Total Long-Term Debt
N/A
N/A
N/A
N/A
3.3M
0.00%
3.3M
0.00%
Total Long-Term Liabilities
231,635
+793.17%
25,934
+2.08%
25,406
-92.95%
360,268
+526.55%
Total Liabilities
895,308
+307.86%
219,512
-65.28%
632,320
-32.59%
938,032
-78.38%
Retained Earnings
-25.2M
+16.58%
-21.6M
+24.84%
-17.3M
+51.30%
-11.4M
+186.24%
Total Stockholders Equity
4.9M
-40.86%
8.2M
-31.68%
12.0M
-29.50%
17.1M
+526.89%
Total Shares Outstanding
494.5M
+3,700.00%
13.0M
0.00%
13.0M
0.00%
13.0M
+30.13%
Cash Flow
Cash from Operating Activities
-3.1M
-22.19%
-4.0M
-19.37%
-5.0M
-5.77%
-5.3M
+586.43%
Capital Expenditures
152,689
+2,740.20%
5,376
-80.37%
27,392
-96.49%
780,876
N/A
Cash from Investing Activities
2.7M
-48.76%
5.2M
+8,789.12%
58,978
+100.55%
-10.8M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
N/A
N/A
102,282
-24.19%
134,913
-99.40%
22.4M
+4,995.12%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-50.50%
+23.62%
-40.85%
+6.60%
-38.32%
-53.68%
-82.73%
N/A
Return on Equity
-54.81%
+28.99%
-42.49%
+5.28%
-40.36%
-65.28%
-116.23%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
7.39
-82.38%
41.92
+118.90%
19.15
-32.72%
28.46
N/A
Cash Ratio
3.65
-76.17%
15.30
+493.31%
2.58
-76.79%
11.11
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
0.52
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
0.50
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow